INTELLIGENT BIO SOLUTIONS INC. (INBS) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US36151G6008

Price
1.93 USD
Market cap
6.40 m USD
P/E (2026)
–
P/S (2026)
1.52
Dividend yield
0.00 %
Net margin
-294.91 %
Return on equity (ROE)
-225.57 %
Return on assets (ROA)
-104.10 %

INTELLIGENT BIO SOLUTIONS INC. financials

Fiscal year20252026
Revenue3.05 m USD4.22 m USD
Gross profit1.25 m USD2.05 m USD
Operating income-10.64 m USD-12.61 m USD
EBIT-10.65 m USD-12.57 m USD
Net income-10.57 m USD-12.43 m USD
Diluted EPS – continuing operations-2.00 USD-8.44 USD

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About INTELLIGENT BIO SOLUTIONS INC.

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.